Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LCTX is expected to report earnings to rise 60.00% to -3 cents per share on March 06

Lineage Cell Therapeutics LCTX Stock Earnings Reports

Q4'24

Est.

$-0.03

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.02

Q1'24

Est.

$-0.04

Q4'23

Beat

by $0.01

The last earnings report on November 14 showed earnings per share of -1 cents, beating the estimate of -3 cents. With 1.88M shares outstanding, the current market capitalization sits at 121.23M.

View a ticker or compare two or three

Compare

LCTX